CD274 and cancer: Despite the significant role of PDT in cancer immunotherapy, strategies involving immune checkpoint blockade, such as the use of PD‐1 and PD‐L1 antibodies, have garnered considerable attention and are increasingly considered frontline cancer drugs [20].